Inventors with similar research interests:
Location History:
- Le Peco, FR (1997)
- Paris, FR (1993 - 1998)
- Le Pecq, FR (1998 - 2012)
Company Filing History:
32 out of 368 
22 out of 290 
1 out of 53 
Years Active: 1993-2012
Title: Mark Millan: An Innovator in Pharmaceutical Patents
Introduction:
Mark Millan, a prolific inventor in the field of pharmaceuticals, hails from Le Pecq, FR, and has made significant contributions to the development of novel compounds and their applications in medication. With an impressive portfolio of 55 patents, Millan's expertise has greatly influenced the pharmaceutical industry. This article aims to highlight his latest patents, career highlights, collaborations, and acknowledge his impactful contributions.
Latest Patents:
Among his recent patents, one notable invention includes "Chromene compounds, a process for their preparation and pharmaceutical compositions containing them." These compounds, with a specific chemical formula, offer therapeutic advantages as D3 receptor antagonists, potentially benefiting patients with conditions requiring such treatment.
Another significant patent is focused on the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, for the treatment of Generalized Anxiety Disorder. This invention highlights Millan's commitment to finding innovative solutions for mental health conditions.
Career Highlights:
Mark Millan has had an illustrious career, marked by numerous accomplishments and notable roles in prestigious companies. He has worked in companies like Adir et Compagnie and Les Laboratoires Servier, where he has been actively involved in research and development activities. His expertise in the field of pharmaceuticals and his dedication to finding breakthrough solutions have brought him recognition within the industry.
Collaborations:
Throughout his career, Millan has collaborated with esteemed professionals in the field. One of his notable coworkers includes Jean-Louis Peglion, whose contributions have complemented Millan's work. Additionally, his collaboration with Bertrand Goument has further expanded the reach and impact of his inventions. These partnerships have fostered a culture of innovation and knowledge-sharing, leading to remarkable achievements in the pharmaceutical field.
Conclusion:
Mark Millan's exceptional talent as an inventor in the pharmaceutical industry is evident through his extensive patent portfolio, including novel compounds and their applications in medication. His dedication to the development of therapeutic solutions and collaborations with notable professionals have led to transformative advancements in healthcare. Millan's work serves as an inspiration to aspiring inventors and highlights the importance of innovation in addressing medical challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.